Issue · Healthcare

Healthcare

Every healthcare bill, vote, and legislator stance in New Jersey, automatically classified by Maddy, our AI policy reader.

Total bills
11
2026-2027 Regular Session
Top supporter
Maureen Rowan
100% support rate
Top opponent
Bob Auth
6% support rate
Ranked legislators
10
5 support · 5 oppose
Key legislators

Who's moving healthcare in New Jersey

Legislators moving healthcare in New Jersey
Legislator Party Stance Support rate Decisive votes
Maureen Rowan
Maureen Rowan House · District 2
D
Strong +
100% 15
Jim Beach
Jim Beach Senate · District 6
D
Strong +
100% 14
Marisa Sweeney
Marisa Sweeney House · District 25
D
Strong +
100% 14
Anthony Angelozzi
Anthony Angelozzi House · District 8
D
Strong +
100% 13
Dave Bailey
Dave Bailey House · District 3
D
Strong +
100% 13
Bob Auth
Bob Auth House · District 39
R
Strong −
6% 18
John DiMaio
John DiMaio House · District 23
R
Strong −
10% 10
Paul Kanitra
Paul Kanitra House · District 10
R
Strong −
10% 10
Erik Peterson
Erik Peterson House · District 23
R
Strong −
12% 17
Joe Pennacchio
Joe Pennacchio Senate · District 26
R
Strong −
13% 15
Showing 11–11 of 11 bills

All healthcare bills

in committee · New Jersey · Senate Mar 16, 2026

S 301: Classifies 7 Hydroxymitragynine as Schedule I drug.

This bill adds 7-hydroxymitragynine (7-OH), a psychoactive compound found in Kratom, to New Jersey's Schedule I list of controlled substances. It directly affects anyone possessing, manufacturing, distributing, or using 7-OH in the state. Under the law, 7-OH would be classified as a substance with "high potential for abuse" and "no accepted medical use," making it illegal for non-medical purposes. Possession of 1 ounce or more would be a second-degree crime, while smaller amounts would be a third-degree crime under New Jersey's drug laws.
Showing 11 to 11 of 11 bills